George Scorsis
CIK: 0002060026
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
Director
Discretionary Trading P&L
Holdings
About Scorsis George
Scorsis George (SEC CIK 0002060026) files insider reports with the SEC as Director of Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
Signal8 holds 2 ownership filings by Scorsis George (1 Form 3, 1 Form 4), filed between Mar 21, 2025 and Aug 12, 2025. Those filings report 1 transaction, the latest on Aug 8, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Scorsis George's filings is in GAITHERSBURG, MD.
Recent filings by Scorsis George
- Aug 8, 2025: Grant or award of SHPH derivative securities (Form 4, code A).
Other insiders filing for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- HRT FINANCIAL LP, 10% Owner
- Trasolini Ryan, Co-Chief Executive Officer
- Liang Yuying, Chief Financial Officer
- Liriano Angel, Director
- Pathigoda Arachchige Sachin Eranga, Director
- Chambers Adam V, Director